A detailed history of Morgan Stanley transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Morgan Stanley holds 220,261 shares of KZIA stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
220,261
Previous 201,082 9.54%
Holding current value
$1.24 Million
Previous $46,000 104.35%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.19 - $1.24 $3,644 - $23,781
19,179 Added 9.54%
220,261 $94,000
Q2 2024

Oct 17, 2024

BUY
$0.2 - $0.46 $646 - $1,486
3,232 Added 1.63%
201,082 $46,000
Q2 2024

Aug 14, 2024

BUY
$0.2 - $0.46 $646 - $1,486
3,232 Added 1.63%
201,082 $46,000
Q1 2024

Oct 17, 2024

SELL
$0.2 - $0.45 $646 - $1,454
-3,232 Reduced 1.61%
197,850 $61,000
Q1 2024

Aug 16, 2024

SELL
$0.2 - $0.45 $740 - $1,665
-3,700 Reduced 1.84%
197,850 $61,000
Q1 2024

May 15, 2024

SELL
$0.2 - $0.45 $740 - $1,665
-3,700 Reduced 1.84%
197,850 $61,000
Q4 2023

Aug 16, 2024

BUY
$0.39 - $0.99 $182 - $463
468 Added 0.23%
201,550 $88,000
Q4 2023

Feb 13, 2024

BUY
$0.39 - $0.99 $4,524 - $11,484
11,600 Added 6.11%
201,550 $88,000
Q3 2023

Nov 15, 2023

SELL
$0.84 - $1.17 $12,264 - $17,082
-14,600 Reduced 7.14%
189,950 $189,000
Q2 2023

Aug 14, 2023

BUY
$1.03 - $1.55 $5,253 - $7,905
5,100 Added 2.56%
204,550 $237,000
Q1 2023

May 15, 2023

SELL
$0.73 - $1.16 $42,260 - $67,153
-57,891 Reduced 22.5%
199,450 $205,000
Q4 2022

Feb 14, 2023

BUY
$0.5 - $1.23 $26,445 - $65,055
52,891 Added 25.87%
257,341 $156,000
Q3 2022

Nov 14, 2022

BUY
$1.1 - $4.19 $3,129 - $11,920
2,845 Added 1.41%
204,450 $224,000
Q2 2022

Oct 27, 2022

SELL
$4.1 - $8.38 $376,261 - $769,040
-91,771 Reduced 31.28%
201,605 $846,000
Q2 2022

Aug 15, 2022

SELL
$4.1 - $8.38 $376,261 - $769,040
-91,771 Reduced 31.28%
201,605 $846,000
Q1 2022

Oct 27, 2022

BUY
$6.05 - $8.65 $555,214 - $793,819
91,771 Added 45.52%
293,376 $2.26 Million
Q1 2022

May 13, 2022

SELL
$6.05 - $8.65 $36,602 - $52,332
-6,050 Reduced 2.02%
293,376 $2.26 Million
Q4 2021

Feb 14, 2022

BUY
$7.35 - $12.0 $88,788 - $144,960
12,080 Added 4.2%
299,426 $2.52 Million
Q3 2021

Nov 15, 2021

BUY
$8.65 - $11.64 $2.49 Million - $3.34 Million
287,346 New
287,346 $3.25 Million

Others Institutions Holding KZIA

About KAZIA THERAPEUTICS LTD


  • Ticker KZIA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,111,300
  • Market Cap $84.8M
  • Description
  • Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...
More about KZIA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.